#Sabcs

Today at #SABCS25, we spoke with Anna Wassman-Cox, founder of Onco-Ballet (@oncoballet), who shared how movement was vital through her two breast cancer diagnoses and how research continues to show the importance of exercise. She also shared her passion for improving care for fellow Asian American patients. With Asian American women now representing the largest group of breast cancer patients under 40, research and representation have never been more important.

"It's so important to always have advocates involved because it allows us to ask those questions to researchers like 'how will this help?'" - Komen patient advocate Bob Ritter shares his thoughts on all the research updates coming from @sabreastcancersymposium #SABCS

Clinical trials aren’t a last resort — they’re a proactive choice. With data showing 35–40% improved outcomes, participation can start early, even for those without a diagnosis but considered high risk, while helping advance care for future patients. As Dr. Alison Stopeck shared during #SABCS, joining a clinical trial is a moment of agency — becoming a superhero for tomorrow’s cures. 🎥 Click the link in our bio to watch the full conversation.

“I think it’s very important that we remember that we belong in these spaces just as much as the doctors do” ~Miranda Patient advocates Veronica & Miranda talk about their experiences as second and first year San Antonio Breast Cancer Symposium attendees 🏔️ #WAHTMM

Last Day at the @sabreastcancersymposium! Come visit us at the @my_faulty_gene booth until 3pm. We’d love to meet you! I am so excited to share some of the research and patient organization/resources that I’ve had the opportunity to learn about & connect with this week. Heading home tonight—and can’t wait to share more! #hereditarycancer #sabcs #genetictesting #breastcancer

SABCS with @drsusanlovefoundation There is so much to unpack from my first experience at SABCS and while I take the time to do that I am also thinking about how grateful I am for @meeshpauline , @allieco_xo and @amazingmendoza of the @drsusanlovefoundation It’s been said that if you want to go fast, go alone but if you want to go far, go together. This may come as a surprise (or it may not) but a lot of the established foundations and organizations don’t go out of their way to help us younger orgs. There is a lot of gate keeping and protecting of contacts and resources. The team at the @drsusanlovefoundation couldn’t be farther from that. They don’t gatekeep, they hold the door wide open. All week they made introductions to contacts they have cultivated over years, showed us the ropes, helped us set meetings and invited us to advocacy dinners. I would have felt 🤯 if it weren’t for them! They also did what NO ONE else has done, they invited us advocates into their huge meetings. They didn’t tell us what to say, they genuinely wanted us there and for our voices and experiences to be heard by the companies and organizations that serve us. They are true leaders and mentors to me for the way they have a true abundance mindset and want us all to win. This was the true epitome of collaboration over competition and I’m so inspired and grateful 🥹🫶

What if AI data review could change the future of breast cancer?! At SABCS, new data from the TAILORx trial showed how artificial intelligence may improve how we predict breast cancer recurrence for early-stage, hormone-positive patients. By integrating routine pathology images with molecular and clinical data, this AI model outperformed the standard Oncotype DX score — especially when it came to identifying late recurrence risk years after treatment. COMMENT “TRIAL” And I’ll send you the update summary. @bcrfcure also did a great breakdown of this update! As a breast cancer survivor and patient advocate, I’m cautious about AI hype. But this research stood out because it focuses on reducing harm: fewer people being overtreated, more confidence in treatment decisions, and better long-term planning for survivorship. This isn’t ready for clinics yet — but it’s a powerful example of how AI can be used thoughtfully to personalize care, not replace clinicians. Would you want AI involved if it meant fewer people getting unnecessary chemo? ➡️ Follow @mycancerchic for survivor-friendly breakdowns of breast cancer research and real-world impact 🩷

Las pacientes con cáncer de mama triple negativo muchas veces se sienten invisibles. Este estudio fase 1 presentado en SABCS 2025 es temprano, pero demuestra que la ciencia específica para TNBC sigue avanzando. @doctorbarrero @sabreastcancersymposium #cáncer #cáncerdemama #TripleNegativo

Estudos apresentados no SABCS 2025, um dos maiores congressos mundiais sobre câncer de mama, mostraram que uma maior ingestão de vegetais crucíferos, como brócolis, couve e couve-flor, está associada a um menor risco de câncer de mama, especialmente dos tumores mais agressivos. Esses vegetais são ricos em glucosinolatos, compostos que, no nosso organismo, se transformam em substâncias com potencial efeito protetor, ajudando a inibir o crescimento de células tumorais. Os dados vêm de dois grandes estudos de acompanhamento com mais de 160 mil mulheres, nos quais a dieta foi avaliada utilizando questionários semiquantitativos de frequência alimentar. Este trabalho reforça que a alimentação é um fator modificável importante no cuidado com a saúde. Inclua vegetais crucíferos no seu dia a dia! É uma estratégia simples, possível e nutritiva. Gostou dessas informações? Compartilhe, para que mais pessoas utilize os alimentos no seu autocuidado 😉🙏 Ref.:Romanos-Nanclares A, et al. Cruciferous vegetable intake, dietary glucosinolate and risk of breast cancer in 2 large prospective studies. SABCS 2025. RF1-07.

Novidades direto do maior congresso de câncer de mama do mundo! 🌎 Você sabia que estamos prestes a ter um novo medicamento, mais eficaz, para o tipo de câncer de mama mais comum? E que as cirurgias estão cada vez menos agressivas, preservando o bem-estar das pacientes? Neste vídeo, explico essas e outras novidades direto do SABCS 2025, no Texas. Falo sobre os avanços que prometem aumentar as chances de cura e a qualidade de vida, e também sobre a importância da cautela com tratamentos para lesões pré-cancerígenas. Assista ao reel para entender as novidades que podem mudar o futuro do tratamento do câncer de mama! 🎗️ #CâncerDeMama #SABCS #Mastologia #SaúdeDaMulher #Prevenção #Tratamento #Medicina #Inovação

During my interview with the SABC’s Abra Barbier, we discussed possible trade agreements between the USA and South Africa. 🇺🇸🇿🇦

Álcool e câncer de mama: não existe consumo “inofensivo”. Os dados apresentados e discutidos na última ASCO e no San Antonio Breast Cancer Symposium (SABCS) reforçam um ponto importante: o risco de câncer de mama aumenta mesmo em mulheres que consomem menos de duas doses de álcool por dia. A partir disso, observa-se uma piora progressiva do risco conforme a quantidade ingerida aumenta, caracterizando uma clara relação dose–resposta. E um alerta fundamental: não adianta concentrar o consumo apenas nos fins de semana. Os estudos mostram que o abuso de álcool (binge drinking) — mesmo que em períodos curtos e esporádicos — pode ser tão ou até mais prejudicial do que um consumo regular moderado, atuando como fator de risco independente. 📌 Reduzir a quantidade total e evitar picos de consumo são estratégias relevantes na prevenção do câncer de mama. Referências: • ASCO Annual Meeting – dados recentes sobre álcool, risco e mortalidade por câncer. • San Antonio Breast Cancer Symposium (SABCS) – sessões científicas sobre fatores de risco modificáveis e impacto do álcool no câncer de mama. Dra Ana Paula Affonso Gomes - Mastologista RQE SC 18573 RS 32671